We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

644 hedge funds and large institutions have $13.5B invested in Charles River Laboratories in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 262 increasing their positions, 235 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 235

0.8% more ownership

Funds ownership: 93.47% → 94.28% (+0.8%)

1% less call options, than puts

Call options by funds: $77.7M | Put options by funds: $78.4M

9% less funds holding

Funds holding: 707 → 644 (-63)

24% less capital invested

Capital invested by funds: $17.7B → $13.5B (-$4.23B)

48% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 115

53% less funds holding in top 10

Funds holding in top 10: 15 → 7 (-8)

Holders
644
Holders Change
-63
Holders Change %
-8.91%
% of All Funds
10.16%
Holding in Top 10
7
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-53.33%
% of All Funds
0.11%
New
60
Increased
262
Reduced
235
Closed
115
Calls
$77.7M
Puts
$78.4M
Net Calls
-$664K
Net Calls Change
-$48.1M

Top Buyers

1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$171M
2
ClearBridge Investments
ClearBridge Investments
New York
+$92.9M
3
Fidelity International
Fidelity International
Bermuda
+$83.3M
4
Two Sigma Investments
Two Sigma Investments
New York
+$53.3M
5
JMPWA
JP Morgan Private Wealth Advisors
California
+$47M

Top Sellers

1
Invesco
Invesco
Georgia
-$142M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$118M
3
Brown Advisory
Brown Advisory
Maryland
-$111M
4
Marshall Wace
Marshall Wace
United Kingdom
-$86.9M
5
ESCM
Echo Street Capital Management
New York
-$65.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
EOJOAM
676
E. Ohman J:or Asset Management
Sweden
– -$829K -2,200 Closed
IC
677
IEQ Capital
California
– -$713K -1,893 Closed
E
678
Ergoteles
New York
– -$681K -1,807 Closed
CRCM
679
Corbett Road Capital Management
Virginia
– -$672K -1,783 Closed
OC
680
Oppenheimer & Co
New York
– -$616K -1,635 Closed
PVH
681
Psagot Value Holdings
Israel
– -$602K -1,597 Closed
BAM
682
Blueshift Asset Management
New Jersey
– -$545K -1,446 Closed
PL
683
Pluribus Labs
California
– -$518K -1,376 Closed
LG
684
Leuthold Group
Minnesota
– -$518K -1,374 Closed
SC
685
Settian Capital
New York
– -$490K -1,300 Closed
SSA
686
Schonfeld Strategic Advisors
New York
– -$483K -1,283 Closed
FBB
687
Fulton Breakefield Broenniman
Maryland
– -$438K -1,163 Closed
SFI
688
Susquehanna Fundamental Investments
Pennsylvania
– -$390K -1,036 Closed
IWA
689
IBEX Wealth Advisors
New Jersey
– -$385K -1,022 Closed
HIM
690
Hotaling Investment Management
Pennsylvania
– -$350K -929 Closed
CIBC World Market
691
CIBC World Market
Ontario, Canada
– -$330K -875 Closed
EA
692
Eudaimonia Advisors
Tennessee
– -$326K -865 Closed
FFM
693
Forum Financial Management
Illinois
– -$323K -856 Closed
TSS
694
Two Sigma Securities
New York
– -$264K -856 Closed
AA
695
ALPS Advisors
Colorado
– -$321K -851 Closed
PDN
696
Pensionfund DSM Netherlands
Netherlands
– -$301K -800 Closed
RCM
697
Regency Capital Management
Hawaii
– -$300K -796 Closed
TPM
698
Triasima Portfolio Management
Quebec, Canada
– -$292K -775 Closed
GT
699
Greenleaf Trust
Michigan
– -$286K -759 Closed
ACM
700
AlphaStar Capital Management
North Carolina
– -$257K -725 Closed
26 27
28
29 30

CRL Hedge Fund Activity: Q1 2022 in Review

644 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2022, worth a combined $13.5B — down 24% from $17.7B a quarter earlier.

Sellers outnumbered buyers: 115 funds closed out of CRL and 60 opened new positions — a net loss of 55 holders — while 235 trimmed existing stakes and 262 added.

The largest buyer was Mackenzie Financial, adding an estimated $171M. The largest seller was Invesco, cutting an estimated $142M.

  • 644 institutional investors held Charles River Laboratories (CRL) as of Q1 2022, down from 707 in Q4 2021.
  • Funds reported $13.5B of Charles River Laboratories stock for Q1 2022, down 24% quarter-over-quarter.
  • 60 funds opened new Charles River Laboratories positions in Q1 2022 and 115 closed out, a net change of -55 holders.
  • The largest Charles River Laboratories buyer in Q1 2022 was Mackenzie Financial, an estimated $171M added.
  • The largest Charles River Laboratories seller in Q1 2022 was Invesco, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2022.